Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.50
Bid: 100.00
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.00%)
Open: 102.50
High: 102.50
Low: 102.50
Prev. Close: 102.50
EAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Sep 2016 15:57

Issue of Share Options

ECO Animal Health Group plc

(“ECO” or the “Company”)

15 September 2016

The Company announces that on 15 September 2016, the Board granted new options to certain Directors of the Company under the Company’s executive share option scheme (“New Options”). The New Options will vest on 15th September 2019 and have been granted as follows:

Director Number of options granted Exercise price
Marc Loomes 400,000 £4.35
Brett Clemo 150,000 £4.35
Julia Trouse 120,000 £4.35
Kevin Stockdale 120,000 £4.35

The aggregate 790,000 New Options issued represents approximately 1.22 per cent of the Company’s existing issued share capital. Following the issue, the Company’s total voting rights remains unchanged at 64,701,206 ordinary shares of 5p each.

PDMR notification - Marc Loomes
1 Details of the Restricted Person/person closely associated with him or her
a) Name: Marc Loomes
2 Reason for the notification
a) Position/Status CEO
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: ECO Animal Health Group plc
b) LEI 01818170
4 Details of the transaction(s): section to be repeated for (i)each type of instrument: (ii) each type of transaction: (iii) each date: and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Option shares of 5p each in the capital of ECO Animal Health Group plc
Identification code ISIN: GB0032036807
b) Nature of transaction Issue of options
c) Prices and volumes 400,000 options at £4.35
d) Aggregate information Volume 400,000 options
Aggregate volume and price Price £4.35 per Option Share
e) Date of transaction 15/09/2016 GMT
f) Place of the transaction London Stock Exchange (XLON) AIM market
PDMR notification - Brett Clemo
1 Details of the Restricted Person/person closely associated with him or her
a) Name: Brett Clemo
2 Reason for the notification
a) Position/Status Executive Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: ECO Animal Health Group plc
b) LEI 01818170
4 Details of the transaction(s): section to be repeated for (i)each type of instrument: (ii) each type of transaction: (iii) each date: and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Option shares of 5p each in the capital of ECO Animal Health Group plc
Identification code ISIN: GB0032036807
b) Nature of transaction Issue of options
c) Prices and volumes Volume 150,000 option shares
Issued at £4.35
d) Aggregate information Volume 150,000 Option Shares
Aggregate volume and price Price £4.35 per Option Share
e) Date of transaction 15/09/2016 GMT
f) Place of the transaction London Stock Exchange (XLON) AIM market
PDMR notification – Julia Trouse
1 Details of the Restricted Person/person closely associated with him or her
a) Name: Julia Trouse
2 Reason for the notification
a) Position/Status Executive Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: ECO Animal Health Group plc
b) LEI 01818170
4 Details of the transaction(s): section to be repeated for (i)each type of instrument: (ii) each type of transaction: (iii) each date: and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Option shares of 5p each in the capital of ECO Animal Health Group plc
Identification code ISIN: GB0032036807
b) Nature of transaction Issue of options
c) Prices and volumes Volume 120,000 option shares
Issued at £4.35
d) Aggregate information Volume 120,000 Option Shares
Aggregate volume and price Price £4.35 per Option Share
e) Date of transaction 15/09/2016 GMT
f) Place of the transaction London Stock Exchange (XLON) AIM market
PDMR notification – Kevin Stockdale
1 Details of the Restricted Person/person closely associated with him or her
a) Name: Kevin Stockdale
2 Reason for the notification
a) Position/Status Finance Director
b) Initial notification/ Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: ECO Animal Health Group plc
b) LEI 01818170
4 Details of the transaction(s): section to be repeated for (i)each type of instrument: (ii) each type of transaction: (iii) each date: and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Option shares of 5p each in the capital of ECO Animal Health Group plc
Identification code ISIN: GB0032036807
b) Nature of transaction Issue of options
c) Prices and volumes Volume 120,000 option shares
Issued at £4.35
d) Aggregate information Volume 120,000 Option Shares
Aggregate volume and price Price £4.35 per Option Share
e) Date of transaction 15/09/2016 GMT
f) Place of the transaction London Stock Exchange (XLON) AIM market
Enquiries
ECO Animal Health Group plc
Peter Lawrence, Executive Chairman 020 8336 6190
Marc Loomes, CEO 020 8447 8899
Spiro Financial
Anthony Spiro 020 8336 6196
Peel Hunt LLP (Nominated Adviser)
Dan Webster, Adrian Trimmings 020 7418 8900

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160915005938/en/

Copyright Business Wire 2016

Date   Source Headline
25th Apr 20247:00 amRNSTrading Update on year ended 31 March 2024
8th Apr 20247:00 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSDisposal of non-core product line
22nd Mar 20247:00 amRNSShare Awards to Executive Directors
21st Mar 20249:13 amRNSReplacement: Trading Update
21st Mar 20247:00 amRNSTrading Update
19th Mar 20249:40 amRNSGeneral Meeting Result
27th Feb 20247:00 amRNSPublication of Notice of General Meeting
6th Feb 20247:00 amRNSTrademark Approval for ECOVAXXIN® family in the EU
8th Jan 20247:00 amRNSDisposal of Freehold Properties
5th Jan 20245:05 pmRNSHolding(s) in Company
5th Jan 20245:00 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSDeferred Option Awards to Executive Directors
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Nov 202310:00 amRNSInvestor Presentation
27th Nov 20237:00 amRNSResults for the six months ended 30 September 2023
14th Nov 20233:00 pmRNSHolding(s) in Company
9th Nov 20237:00 amRNSCapital Markets Day Events
24th Oct 20237:00 amRNSNew USA and Canada label claim for Aivlosin®
28th Sep 20237:00 amRNSESG Rating
7th Sep 20232:57 pmRNSResult of AGM
10th Aug 20237:00 amRNSNotice of AGM
21st Jul 20234:25 pmRNSPosting of the Annual Report and Accounts
10th Jul 20237:00 amRNSFinal Results for the Year Ended 31 March 2023
5th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jun 20237:00 amRNSIssue of Equity and Total Voting Rights
18th May 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSTrading Update
8th Mar 20237:00 amRNSAnimal Health Innovation Summit
27th Feb 202310:37 amRNSDirector/PDMR Shareholding
24th Feb 20233:19 pmRNSChange of Registered Address
17th Feb 20231:41 pmRNSHolding(s) in Company
13th Feb 20231:55 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Jan 202312:14 pmRNSHolding(s) in Company
13th Dec 20223:50 pmRNSDeferred Share Option Awards
30th Nov 20223:01 pmRNSDirector/PDMR Shareholding
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM
31st Aug 20227:00 amRNSFinal Results for the Year Ended 31 March 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.